BELKIN Vision

BELKIN Vision is an Israeli company specializing in glaucoma laser equipment. BELKIN Vision is developing an automated, rapid glaucoma laser treatment method aimed at revolutionizing the accessibility of glaucoma treatment, making it the first-line choice for every glaucoma patient worldwide. BELKIN Vision is addressing the growing gap between the large number of glaucoma patients (67 million) and the limited number of ophthalmologists (212,000), enabling doctors to treat more patients quickly. BELKIN's innovative technology is applicable to the prevalent open-angle glaucoma (OAG, accounting for 70% of glaucoma patients) and will become a pioneer in laser treatment for angle-closure glaucoma (ACG, accounting for 30%), which is the most common type among Asians.